+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Rebamipide (CAS 90098-04-7) Global Market Research Report 2024

  • PDF Icon

    Report

  • 50 Pages
  • November 2024
  • Region: Global
  • Merchant Research and Consulting Ltd
  • ID: 4184537
Description Jump to:
This global report is a result of industry experts’ diligent work on researching the world market of Rebamipide. The report helps to build up a clear view of the market trends and developments, identify major players in the industry, and estimate main downstream sectors.

The Rebamipide global market report's key points:

  • Rebamipide description, applications and related patterns
  • Rebamipide market situation
  • Rebamipide manufacturers and distributors
  • Rebamipide prices
  • Rebamipide end-users
  • Rebamipide downstream industries trends
The first chapter introduces the product (composition, structure, hazards, storage, toxicological & ecological information, etc.).

The second chapter focuses on Rebamipide end-uses. The third chapter summarizes data about manufacturing methods.

The fourth chapter is about the related patents. The fifth chapter deals with Rebamipide market trends and forecast, distinguish Rebamipide manufacturers and suppliers.

The sixth chapter provides Rebamipide prices data.

The seventh chapter analyses Rebamipide downstream markets.


This product will be delivered within 5-7 business days.

Table of Contents

1. REBAMIPIDE GENERAL INFORMATION
1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. REBAMIPIDE APPLICATIONS

3. REBAMIPIDE MANUFACTURING METHODS

4. REBAMIPIDE PATENTS

5. REBAMIPIDE MARKET WORLDWIDE
5.1. Global Rebamipide market analysis: market constraints, drivers and opportunities
5.2. Manufacturers of Rebamipide
  • Europe
  • Asia
  • North America
  • Etc.
5.3. Suppliers of Rebamipide
  • Europe
  • Asia
  • North America
  • Etc.
5.4. Market forecast

6. REBAMIPIDE MARKET PRICES
  • Europe
  • Asia
  • North America
7. REBAMIPIDE END-USE SECTOR

Related Topics

Related Reports

Desipramine (CAS 50-47-5) Global Market Research Report 2024 - Product Image

Desipramine (CAS 50-47-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Ornidazole (CAS 16773-42-5) Global Market Research Report 2024 - Product Image

Ornidazole (CAS 16773-42-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Ranitidine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Ranitidine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Domperidone Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Domperidone Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 103 Pages
  • Global
From
Betaine Market Forecast (2025-2032): Industry Size, Market Share Data, Business Insights, Latest Trends, Opportunities, Competitive Analysis and Demand Outlook Report - Product Image

Betaine Market Forecast (2025-2032): Industry Size, Market Share Data, Business Insights, Latest Trends, Opportunities, Competitive Analysis and Demand Outlook Report

  • Report
  • 148 Pages
  • Global
From

About the Rebamipide Market

Rebamipide is a gastrointestinal drug used to treat gastric and duodenal ulcers, gastritis, and reflux esophagitis. It is a proton pump inhibitor that works by reducing the amount of acid produced in the stomach. It is also used to treat symptoms of gastroesophageal reflux disease (GERD) such as heartburn and acid regurgitation. Rebamipide is available in tablet, capsule, and suspension forms. It is usually taken twice daily with or without food. Rebamipide is a relatively new drug and is not widely available in many countries. It is approved for use in Japan, South Korea, and Taiwan. In Japan, it is the most commonly prescribed proton pump inhibitor. The Rebamipide market is highly competitive, with several companies offering their own versions of the drug. Some of the major players in the market include Takeda Pharmaceuticals, Daiichi Sankyo, Astellas Pharma, and Otsuka Pharmaceuticals. Other companies such as Shionogi & Co., Ltd., and Mitsubishi Tanabe Pharma Corporation also offer Rebamipide products. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.